|
Pediatric Clinical Oncology Research Training Program
|
3K12CA090433-10S1
|
$134,042
|
Poplack, David
|
BAYLOR COLLEGE OF MEDICINE
|
|
Pediatric Clinical Oncology Research Training Program
|
5K12CA090433-10
|
$475,607
|
Poplack, David
|
BAYLOR COLLEGE OF MEDICINE
|
|
Cancer Center Support Grant
|
5P30CA013696-38
|
$3,816,425
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-38S1
|
$74,998
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-38S2
|
$139,995
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Analyses of the Molecular Functions for D-Cyclins
|
5R01CA108420-08
|
$448,113
|
SICINSKI, PIOTR
|
DANA-FARBER CANCER INSTITUTE
|
|
Community Clinical Oncology Program: FL Pediatric CCOP
|
5U10CA035157-28
|
$450,001
|
TALBERT, JAMES
|
FLORIDA ASSN OF PEDIATRIC TUMOR PROG
|
|
Riluzole Prodrugs for Melanoma and ALS
|
1R43CA156781-01
|
$336,255
|
Reitz, Allen
|
FOX CHASE CHEMICAL DIVERSITY CENTER, INC
|
|
Regulatory mechanisms and role of the PI3K-TSC-mTOR signaling network in tumors
|
5R01CA122617-06
|
$258,308
|
MANNING, BRENDAN
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
|
Research Training in Neuro-Oncology
|
5T32CA009574-24
|
$238,542
|
GROSSMAN, STUART
|
JOHNS HOPKINS UNIVERSITY
|
|
North Central Cancer Treatment Group
|
3U10CA025224-32S1
|
$1,347,651
|
BUCKNER, JAN
|
MAYO CLINIC
|
|
North Central Cancer Treatment Group
|
5U10CA025224-32
|
$5,018,658
|
BUCKNER, JAN
|
MAYO CLINIC
|
|
Children's Oncology Group Chair's Grant
|
3U10CA098543-09S3
|
$1,375,035
|
ADAMSON, PETER
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Chair's Grant
|
5U10CA098543-09
|
$26,766,352
|
ADAMSON, PETER
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Statistics and Data Center Grant
|
5U10CA098413-09
|
$5,780,843
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Community Clinical Oncology program Research Base
|
5U10CA095861-10
|
$1,464,654
|
POLLOCK, BRAD
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
The Synergy Between Radiotherapy and Molecularly Targeted Agents
|
ZIA SC 010373
|
$1,227,708
|
Camphausen, Kevin
|
CCR (NCI)
|
|
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
|
ZIA BC 010006
|
$489,703
|
Daar, Ira
|
CCR (NCI)
|
|
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
|
ZIA BC 010958
|
$489,703
|
Daar, Ira
|
CCR (NCI)
|
|
Brain Tumor Clinical and Clinical Research Program
|
ZID BC 011098
|
$2,547,976
|
Fine, Howard
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$548,663
|
Gottesman, Michael
|
CCR (NCI)
|
|
Cutaneous Lesions in Neurofibromatosis Type I and Other Pre-cancerous Syndromes
|
ZIA BC 010734
|
$48,425
|
Hornyak, Thomas
|
CCR (NCI)
|
|
Targeting High-risk Neuroblastoma using high through put siRNA screening
|
ZIA BC 010806
|
$322,491
|
Khan, Javed
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$881,476
|
Khan, Javed
|
CCR (NCI)
|
|
Micro RNA Profiling in Pediatric Cancers
|
ZIA BC 011001
|
$107,497
|
Khan, Javed
|
CCR (NCI)
|
|
Identification of Genes for Predicting Prognosis in Pediatric Cancers
|
ZIA SC 010366
|
$214,994
|
Khan, Javed
|
CCR (NCI)
|
|
Postmortem Pathology
|
ZIC BC 010685
|
$420,341
|
Kleiner, David
|
CCR (NCI)
|
|
DNA Repair in Human Cancer-Prone Genetic Diseases
|
ZIA BC 004517
|
$1,420,622
|
Kraemer, Kenneth
|
CCR (NCI)
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$552,204
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIA BC 011038
|
$1,104,407
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Clinical Nursing and Data Management Core
|
ZID BC 011089
|
$828,305
|
Linehan, W. Marston
|
CCR (NCI)
|
|
RNA interference approach to dissect roles of notochord regulators
|
ZIA BC 011121
|
$80,056
|
Mackem, Susan
|
CCR (NCI)
|
|
Protein Structure, Stability, and Amyloid Formation
|
ZIA BC 010440
|
$475,236
|
Nussinov, Ruth
|
CCR (NCI)
|
|
Consequences of receptor cross talk on inflammation and algesia
|
ZIA BC 010708
|
$56,648
|
Oppenheim, Joost
|
CCR (NCI)
|
|
Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma
|
ZIA BC 010539
|
$644,844
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Molecular Mechanisms of Proliferation and Infiltration of Astrocytoma
|
ZIA BC 010540
|
$184,241
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Development of Mouse Astrocytoma Model for Preclinical Testing
|
ZIA BC 010541
|
$92,121
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Role of Neurotrophins in the Development of the Mammalian Nervous System
|
ZIA BC 010390
|
$388,254
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Role of Trk Receptors in the Development and Function of Non-neuronal Structures
|
ZIA BC 010391
|
$388,254
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma
|
ZIA BC 010788
|
$469,166
|
Thiele, Carol
|
CCR (NCI)
|
|
Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma
|
ZIA BC 010789
|
$469,166
|
Thiele, Carol
|
CCR (NCI)
|
|
IL-2/IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
|
ZIA SC 004002
|
$1,295,164
|
Waldmann, Thomas
|
CCR (NCI)
|
|
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression
|
ZIA BC 010015
|
$328,101
|
Wang, Ji Ming
|
CCR (NCI)
|
|
Iowa Womens Health Study Drinking Water Nitrate Analysis
|
ZIA CP010125-10347
|
$32,379
|
Ward, Mary
|
DCEG (NCI)
|
|
Phase II Trial of O6-Benzylguanine and Temozolomide in Pediatric Patients with Hi
|
ZIA BC 010590
|
$46,106
|
Warren, Katherine
|
CCR (NCI)
|
|
An Exploratory Study of Biologic and Pathophysiologic Efects of Radiation Therap
|
ZIA BC 010709
|
$138,319
|
Warren, Katherine
|
CCR (NCI)
|
|
Determining the Fate of Transmembrane Proteins
|
ZIA BC 009392
|
$733,412
|
Weissman, Allan
|
CCR (NCI)
|
|
Development of Therapies for Neurofibromatosis Type 1 Related Tumors and other Ge
|
ZIA BC 010801
|
$976,696
|
Widemann, Brigitte
|
CCR (NCI)
|
|
Clinical Development of Novel Drugs for Children with Refractory Cancers
|
ZIA SC 010354
|
$651,131
|
Widemann, Brigitte
|
CCR (NCI)
|
|
Nanomaterials for Cancer Diagnostics and Therapeutics
|
3U54CA151880-02S1
|
$57,724
|
MIRKIN, CHAD
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|